The TNF receptor super family in immune regulation

Immunological Reviews

Volumn 244, Issue 1, 2011, Pages 5-8

  Ware, Carl F ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURISTATIN; BRENTUXIMAB VEDOTIN; CD30 ANTIGEN; I KAPPA B; LYMPHOTOXIN ALPHA BETA; OX40 LIGAND; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; HODGKIN DISEASE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; UBIQUITINATION; VIRUS INFECTION;

ANIMALS; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; DRUG DESIGN; HUMANS; IMMUNITY; MICE; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054850038     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2011.01065.x     Document Type: Note

References (22)

1. Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002;27:19-26.
2. Feldmann M, Maini RN. Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? J Immunol 2010;185:791-794.
3. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005;23:787-819.
4. Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2010;2:a000109.
5. Walczak H. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev 2011;244:9-28.
6. Schröfelbauer B, Hoffmann A. How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members? Immunol Rev 2011;244:29-43.
7. Razani BM, Devi Reichardt A, Cheng G. Noncanonical NF-κB signaling activation and regulation: principles and perspectives. Immunol Rev 2011;244:44-54.
8. Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions. Immunol Rev 2011;244:55-74.
9. Zhu M, Fu Y-X. The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling. Immunol Rev 2011;244:75-84.
10. Gommerman JL, Summers deLuca L. LTβR and CD40: working together in dendritic cells to optimize immune responses. Immunol Rev 2011;244:85-98.
11. Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol Rev 2011;244:99-114.
12. Rickert RC, Jullosova J, Miletic AV. Signaling by the TNFR superfamily in B-cell biology and disease. Immunol Rev 2011;244:115-133.
13. So T, Lee SW, Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 2006;83:1-11.
14. + T-cell memory but not effector function. Immunol Rev 2011;244:134-148.
15. + T-cell vaccines against respiratory viruses. Immunol Rev 2011;244:149-168.
16. Steinberg MW, Cheung TC, Ware CF. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol Rev 2011;244:169-187.
17. Meylan F, Richard AC, Siegel RM. TL1A and DR3, a TNF family ligand-receptor pair that promotes lympocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol Rev 2011;244:188-196.
18. Snell LM, Yin GHY, McPherson AJ, Moraes TJ, Watts TH. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol Rev 2011;244:197-217.
19. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011;365:725-733.
20. Weinberg AD, Morris NP, Kovacsovics-Bankowski M, Urba WJ, Curti BD. Science Gone Translational: The OX40 Agonist Story. Immunol Rev 2011;244:218-231.
21. Foyil KV, Bartlett NL. Anti-CD30 Antibodies for Hodgkin lymphoma. Curr Hematol Malig Rep 2010;5:140-147.
22. Francisco JA, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 2003;102:1458-1465.